Ayaka Mizumoto

Ms. Ayaka Mizumoto

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AMAyaka Mizumoto
Ayaka Mizumoto
SOShinya Ohashi
Shinya Ohashi
KHKenshiro Hirohashi
Kenshiro Hirohashi
YAYusuke Amanuma
Yusuke Amanuma
TMTomonari Matsuda
Tomonari Matsuda
MMManabu Muto
Manabu Muto
Acetaldehyde is a highly reactive compound that causes various forms of damage to DNA, including DNA adducts, single- and/or double-strand breaks (DSBs), point mutations, sister chromatid exchanges (SCEs), and DNA–DNA cross-links. Among these, DNA adducts such as N2-ethylidene-2′-deoxyguanosine, N2-ethyl-2′-deoxyguanosine, N2-propano-2′-deoxyguanosine, and N2-etheno-2′-deoxyguanosine are central to acetaldehyde-mediated DNA damage because they are associated with the induction of DNA mutations, DNA–DNA cross-links, DSBs, and SCEs. Acetaldehyde is produced endogenously by alcohol metabolism and is catalyzed by aldehyde dehydrogenase 2 (ALDH2). Alcohol consumption increases blood and salivary acetaldehyde levels, especially in individuals with ALDH2 polymorphisms, which are highly associated with the risk of squamous cell carcinomas in the upper aerodigestive tract. Based on extensive epidemiological evidence, the International Agency for Research on Cancer defined acetaldehyde associated with the consumption of alcoholic beverages as a “group 1 carcinogen” (definite carcinogen) for the esophagus and/or head and neck. In this article, we review recent advances from studies of acetaldehyde-mediated carcinogenesis in the squamous epithelium, focusing especially on acetaldehyde-mediated DNA adducts. We also give attention to research on acetaldehyde-mediated DNA repair pathways such as the Fanconi anemia pathway and refer to our studies on the prevention of acetaldehyde-mediated DNA damage.

8 February 2019 in Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
AMAyaka Mizumoto
Ayaka Mizumoto
SOShinya Ohashi
Shinya Ohashi
MKMayumi Kamada
Mayumi Kamada
TSTomoki Saito
Tomoki Saito
YNYukie Nakai
Yukie Nakai
MMManabu Muto
Manabu Muto
Background Esophageal squamous cell carcinoma (ESCC) is one of the most intractable cancers, so the development of novel therapeutics has been required to improve patient outcomes. Curcumin, a polyphenol from Curcuma longa, exhibits various health benefits including antitumor effects, but its clinical utility is limited because of low bioavailability. Theracurmin® (THC) is a highly bioavailable curcumin dispersed with colloidal submicron particles. Methods We examined antitumor effects of THC on ESCC cells by cell viability assay, colony and spheroid formation assay, and xenograft models. To reveal its mechanisms, we investigated the levels of reactive oxygen species (ROS) and performed microarray gene expression analysis. According to those analyses, we focused on NQO1, which involved in the removal of ROS, and examined the effects of NQO1-knockdown or overexpression on THC treatment. Moreover, the therapeutic effect of THC and NQO1 inhibitor on ESCC patient-derived xenografts (PDX) was investigated. Results THC caused cytotoxicity in ESCC cells, and suppressed the growth of xenografted tumors more efficiently than curcumin. THC increased ROS levels and activated the NRF2–NMRAL2P–NQO1 expressions. Inhibition of NQO1 in ESCC cells by shRNA or NQO1 inhibitor resulted in an increased sensitivity of cells to THC, whereas overexpression of NQO1 antagonized it. Notably, NQO1 inhibitor significantly enhanced the antitumor effects of THC in ESCC PDX tumors. Conclusions These findings suggest the potential usefulness of THC and its combination with NQO1 inhibitor as a therapeutic option for ESCC.

1 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
AKAoi Komatsu
Aoi Komatsu
KMKotaro Matsumoto
Kotaro Matsumoto
YYYuki Yoshimatsu
Yuki Yoshimatsu
YSYooksil Sin
Yooksil Sin
AKArisa Kubota
Arisa Kubota
FTFuyuhiko Tamanoi
Fuyuhiko Tamanoi
(1) Background: CIC-DUX4 sarcoma is a rare mesenchymal small round cell tumor which belongs to rare cancers that occupy a significant percentage of cancer cases as a whole, despite each being rare. Importantly, each rare cancer type has different features, and thus there is a need to develop a model that mimics the features of each of these cancers. We evaluated the idea that the chicken chorioallantoic membrane assay (CAM), a convenient and versatile animal model, can be established for the CIC-DUX4 sarcoma. (2) Methods: Patient-derived cell lines of CIC-DUX4 were applied. These cells were transplanted onto the CAM membrane and tumor formation was examined by H&E staining, immunohistochemistry and Western blotting. The CAM tumor was transferred onto a fresh CAM and was also used to form organoids. Retention of the fusion gene was examined. (3) Results: H&E staining as well as molecular characterization demonstrated the formation of the CIC-DUX4 tumor on the CAM membrane. Expression of cyclin D2 and ETV4 was identified. The CAM tumor was transferred to a fresh CAM to form the second-generation CAM tumor. In addition, we were successful in forming tumor organoids using the CAM tumor. Retention of the fusion gene CIC-DUX4 in the CAM, second-generation CAM, and in the CAM-derived organoids was confirmed by RT-PCR. (4) Conclusions: The CAM assay provides a promising model for CIC-DUX4 sarcoma.

26 August 2023 in Genes to Cells
Verified
Journal Article
Open access
AMAyaka Mizumoto
Ayaka Mizumoto
YYYuta Yokoyama
Yuta Yokoyama
TMTomoichiro Miyoshi
Tomoichiro Miyoshi
MTMasahiro Takikawa
Masahiro Takikawa
FIFuyuki Ishikawa
Fuyuki Ishikawa
MSMahito Sadaie
Mahito Sadaie
The guanine‐rich stretch of single‐stranded DNA (ssDNA) forms a G‐quadruplex (G4) in a fraction of genic and intergenic chromosomal regions. The probability of G4 formation increases during events causing ssDNA generation, such as transcription and replication. In turn, G4 abrogates these events, leading to DNA damage. DHX36 unwinds G4‐DNA in vitro and in human cells. However, its spatial correlation with G4‐DNA in vivo and its role in genome maintenance remain unclear. Here, we demonstrate a connection between DHX36 and G4‐DNA and its implications for genomic integrity. The nuclear localization of DHX36 overlapped with that of G4‐DNA, RNA polymerase II, and a splicing‐related factor. Depletion of DHX36 resulted in accumulated DNA damage, slower cell growth, and enhanced cell growth inhibition upon treatment with a G4‐stabilizing compound; DHX36 expression reversed these defects. In contrast, the reversal upon expression of DHX36 mutants that could not bind G4 was imperfect. Thus, DHX36 may suppress DNA damage by promoting the clearance of G4‐DNA for cell growth and survival. Our findings deepen the understanding of G4 resolution in the maintenance of genomic integrity.

1 April 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
AMAyaka Mizumoto
Ayaka Mizumoto
SOShinya Ohashi
Shinya Ohashi
KHKenshiro Hirohashi
Kenshiro Hirohashi
YNYukie Nakai
Yukie Nakai
JMJunichi Matsubara
Junichi Matsubara
MMManabu Muto
Manabu Muto

1 April 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
KHKenshiro Hirohashi
Kenshiro Hirohashi
SOShinya Ohashi
Shinya Ohashi
YNYukie Nakai
Yukie Nakai
AMAyaka Mizumoto
Ayaka Mizumoto
MYMasahiro Yoshioka
Masahiro Yoshioka
MMManabu Muto
Manabu Muto